In recent months, dozens of blood pressure drugs from factories in China and India were recalled globally after tests conducted by U.S. federal agency, the Food and Drug Administration (FDA), and other international inspection agencies revealed that the drugs contained cancer-causing impurities in trace amounts.
The FDA is now conducting a root-cause investigation into the underlying causes of the carcinogens found in commonly prescribed heart and blood pressure medications including valsartan, irbesartan, and losartan.
